drugset

drugset / Trial / NCT01233570

Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

NCT01233570 ↗

Phase 2 Completed 20 enrolled University of Aberdeen

NaSingle-groupOpen-labelTreatment

Summary

An assessment of the efficacy of topical tacrolimus in the treatment of cutaneous crohns disease

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	0.1 %	Topical

Indications